SCHEMBL8738

SCHEMBL8738

O=c1c(-c2ccccc2)c(CCSc2ncnc3[nH]cnc23)oc2ccc(Br)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 3/20 0.40
PIM1 P11309 1/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
PIM3 Q86V86 1/20 0.40
CSNK2A3 Q8NEV1 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
MAPT P10636 4/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9452 0.91 CDC7 (0.41) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL29651571 0.91 CDC7 (0.41) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL15528156 0.83 CDC7 (0.41) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL8468 0.81 CDC7 (0.42) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL30670894 0.81 CDC7 (0.42) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL30013089 0.81 CA1 (0.42) CDC7MAPTTSHRLMNACA1
SCHEMBL8084 0.81 CA1 (0.42) CDC7MAPTTSHRLMNACA1
SCHEMBL30013651 0.79 CSNK2B (0.40) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL9161 0.79 CSNK2B (0.40) CDC7PIM1CSNK2A2CSNK2BCSNK2A1
SCHEMBL8656 0.74 GABRP (0.49) MAPTTSHRALOX12GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP claimed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO claimed
EP-4292596-A1 METHOD AND COMBINATION FOR TREATING TUMORS Curon Biopharmaceutical (Shanghai) Co., Limited (CN) 2023-12-20 EP disclosed
EP-2916868-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR Rhizen Pharmaceuticals S.A. (CH) 2015-09-16 EP disclosed
WO-2014072937-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR RHIZEN PHARMACEUTICALS SA (CH) 2014-05-15 WO disclosed
EP-2496567-A2 NOVEL BENZOPYRAN KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2012-09-12 EP disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO disclosed